Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 190,000 VKTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | Viking Therapeutics, Inc. (VKTX) | Grant/Award | 190,000 | n/a |
| Jan 3, 2024 | Forte Biosciences, Inc. (FBRX) | Exercise/Conversion | 7,500 | n/a |
| Oct 3, 2023 | Forte Biosciences, Inc. (FBRX) | Exercise/Conversion | 7,500 | n/a |
| Aug 2, 2023 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 74,257 | $75.0K |
| Jul 5, 2023 | Forte Biosciences, Inc. (FBRX) | Exercise/Conversion | 7,500 | n/a |
| Apr 5, 2023 | Forte Biosciences, Inc. (FBRX) | Exercise/Conversion | 7,500 | n/a |
| Feb 28, 2023 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 120,000 | n/a |
| Jun 8, 2022 | Forte Biosciences, Inc. (FBRX) | Grant/Award | 250,000 | n/a |